stars 1 stars 2 stars 3

Nepsone is a preclinical-stage pharmaceutical company developing drugs to treat dermatological conditions that arise due to an imbalance in the autonomic nervous system. Currently, these conditions are believed to originate in the immune system. Nepsone foundational neuroimmunology theory on the origin of psoriasis teaches us that an imbalance in neuropeptide activity in the body leads to these conditions. Our drugs are designed to utilize the body’s natural mechanisms to bring back balance and alleviate the disease.

Nepsone ehf Questions

The Nepsone ehf annual revenue was $2 million in 2026.

Stefan Sveinsson is the CEO of Nepsone ehf.

4 people are employed at Nepsone ehf.

The NAICS codes for Nepsone ehf are [325, 32, 3254, 32541].

The SIC codes for Nepsone ehf are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users